Stanley Weng
Papers
1
Total Citations
10
H-Index
1
About
Dr. Stanley Weng is a urologic oncologist whose research focuses on improving outcomes for patients with kidney cancer, particularly through the study of minimally invasive surgical techniques. His most cited work, “Outcomes for Atypical Tumor Recurrences Following Minimally Invasive Kidney Cancer Operations” (2022, 10 citations), provides critical insights into rare but serious complications after laparoscopic or robotic nephrectomy. In this study, Dr. Weng characterized atypical tumor recurrences (ATR)—including port-site metastases, intraperitoneal carcinomatosis, and nephrectomy bed implants—and analyzed their clinical management and prognostic implications. By identifying patterns in these unusual recurrences, his work helps surgeons refine patient selection and follow-up protocols, ultimately enhancing safety in minimally invasive kidney cancer surgery. Dr. Weng’s contributions bridge surgical innovation with oncologic vigilance, offering practical guidance for managing challenging postoperative scenarios. His research is valuable for urologists and surgical oncologists seeking to balance the benefits of MIS with a thorough understanding of its potential long-term risks.
Research Focus
Key Achievements
Top Papers
- 1